Effect of Tranexamic acid on mortality and morbidity in spontaneously ICH patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191014045103N1

Enrollment

Registered

2019-11-23

Start date

2019-12-06

Completion date

Unknown

Last updated

2019-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral hemorrhage. Nontraumatic intracerebral hemorrhage in hemisphere, subcortical

Interventions

Intervention 1: Intervention group: 47 patients with spontaneous ICH receive tranexamic acid, 1 g bolus in the first 10 minutes and 1 g intravenous infusion in the first 8 hours. Patients are then as

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Spontaneous ICH Patients Refer to Emergency Department of Arak Amiralmomenin Hospital in Arak

Exclusion criteria

Exclusion criteria: The patient is a candidate for surgery Patient with documented cerebral venous thrombosis (CVT) and documented venous thrombosis

Design outcomes

Primary

Measure	Time frame
Duration of hospitalization. Timepoint: After the injection. Method of measurement: Admitted by checklist as number of days hospitalization.;Evaluation of the patient's clinical condition. Timepoint: After the injection. Method of measurement: Checklist and NIHSS questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactOmid Ezati

Arak University of Medical Sciences

i.am.khodam.dg@gmail.com+98 86 4622 9116

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026